XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Tables)
6 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of operating lease costs
            
   Three months ended March 31,  Six months ended March 31,
   2024  2023  2024  2023
Operating lease costs  $31   $30   $61   $60 
Schedule of contribution plan
            
   Three months ended March 31,  Six months ended March 31,
   2024  2023  2024  2023
Contributions to 401(k) plan  $94   $56   $167   $100 
Schedule of share purchase warrants outstanding
          
Number  Exercise Price  Expiry Date
 150,000   $3.17   May 6, 2024
 10,000   $12.00   April 21, 2026
 160,000         
Schedule of outstanding stock purchase options
            
      Weighted Average Exercise Price  Weighted Average Grant Date Fair Value  Aggregate intrinsic value
   Number of Options  ($)  ($)  ($)
 Outstanding, September 30, 2022    13,169,616    6.61    4.96    62,267,309 
 Granted    1,959,000    9.30    6.60     
 Exercised    (759,753)   2.34    0.95    4,629,026 
 Forfeited    (257,083)   12.00    6.74     
 Outstanding, September 30, 2023   14,111,780   7.12   5.27   22,290,069 
 Granted    1,750,500    5.53    3.99     
 Exercised    (46,000)   3.43    2.60    125,170 
 Forfeited    (221,166)   13.84    9.06     
 Outstanding, March 31, 2024    15,595,114    6.85         12,480,916 
 Exercisable, March 31, 2024   9,955,616   5.38       12,440,416 
Schedule of summarized information about stock options
                  
Range of exercises prices 

Number of

outstanding

 

Weighted average

remaining

contractual life (in

  Weighted average 

Number of

vested

 

Weighted

average

From  To  options  years)  exercise price  options  exercise price
$0.92   $3.00    3,243,060    4.22    2.38    3,243,060   $2.38 
$3.01   $5.00    2,167,500    4.24    3.39    2,017,500   $3.28 
$5.01   $9.00    6,790,554    6.62    6.58    3,436,472   $6.19 
$9.01   $13.00    1,894,000    7.85    10.53    705,667   $11.06 
$13.01   $25.00    1,500,000    6.97    18.12    552,917   $18.28 
          15,595,114    5.97   6.85   9,955,616   5.38 
Schedule of general and administrative expenses and research and development expenses
                    
   Three months ended March 31,  Six months ended March 31,
   2024  2023  2024  2023
General and administrative  $979   $1,257   $1,905   $3,000 
Research and development   1,673    2,713    3,033    6,317 
Total stock-based compensation  $2,652   $3,970   $4,938   $9,317 
Schedule of weighted average assumptions
          
   2024  2023
Risk-free interest rate   4.28%   3.69%
Expected life of options (years)   5.74    5.61 
Annualized volatility   84.84%   85.28%
Dividend rate   0.00%   0.00%